Pre-Exposure Prophylaxis for HIV

CE Information
1.0 contact hour (1.0 pharmacology)
Completion Time
1 hour
Available Until
December 31, 2024
Ready to start this activity?
Already registered? Please log in to see your registration information.
You will be redirected to the association site for Pacific Lutheran University Center for Continued Nursing Learning to complete your registration.

Overview

Specialties
Educational/Research, Nursing Student, and School Health
Clinical Topics
AIDS/HIV, Health Literacy, Pharmacology, Primary Care, and Treatment

This course will cover Pre-Exposure Prophylaxis (PrEP) effectiveness in preventing HIV infection when taken as prescribed. PrEP is recommended for individuals at high risk of HIV, and it involves taking antiretroviral medications regularly to reduce the risk of HIV transmission. Discover the importance of healthcare providers accessing individuals' risk factors to determine if PrEP is appropriate for them.  PrEP is highly effective when taken consistently. The two main medications approved for PrEP are Truvada (tenofovir disoproxil fumarate/emtricitabine) and Descovy (tenofovir alafenamide/emtricitabine). Both medications have been shown to significantly reduce the risk of HIV transmission when taken as directed.

Speakers

Kathryn Schroeder PharmD, BCACP

Clinical Ambulatory Care Pharmacy Specialist

CE Information

This activity offers 1.0 contact hour (1.0 pharmacology) to attendees.

Activity Content

Key:
Locked
Next
Complete
Failed
0% Complete
Activity Attachments

Registration to this activity includes access to the following supporting materials.

  • CDC 2022 Opioid Guideline update CCNL 20230506L.pdf (Size: 5.8 MB)
Presentation
Duration: about 1 hour | Quality: HD
Course Evaluation
5 questions
Certificate
Access your certificate

Register For This Activity

Pre-Exposure Prophylaxis for HIV

$35.00